NEW YORK (GenomeWeb) – Sygnis said today that it has signed a second contract with Chinese proteomics firm Tanon under which Tanon will sell Sygnis products to the Chinese market.

The deal expands a previous agreement between Sygnis and Tanon covering rights to Sygnis's precast gels. The new deal adds rights to the company's InstantBlue stain for protein detection and its Ultrafast blotting buffer for use in western blotting assays.

Tanon will sell the Sygnis products to the Chinese market under the Tanon name.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.